Olga Nikolova1, Russell Moser2, Christopher Kemp2, Mehmet Gönen1,3, Adam A Margolin1. 1. Computational Biology Program, Oregon Health and Science University, Portland, OR 97239, USA. 2. Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. 3. Department of Industrial Engineering, Koç University, İstanbul, Turkey.
Abstract
Motivation: In recent years, vast advances in biomedical technologies and comprehensive sequencing have revealed the genomic landscape of common forms of human cancer in unprecedented detail. The broad heterogeneity of the disease calls for rapid development of personalized therapies. Translating the readily available genomic data into useful knowledge that can be applied in the clinic remains a challenge. Computational methods are needed to aid these efforts by robustly analyzing genome-scale data from distinct experimental platforms for prioritization of targets and treatments. Results: We propose a novel, biologically motivated, Bayesian multitask approach, which explicitly models gene-centric dependencies across multiple and distinct genomic platforms. We introduce a gene-wise prior and present a fully Bayesian formulation of a group factor analysis model. In supervised prediction applications, our multitask approach leverages similarities in response profiles of groups of drugs that are more likely to be related to true biological signal, which leads to more robust performance and improved generalization ability. We evaluate the performance of our method on molecularly characterized collections of cell lines profiled against two compound panels, namely the Cancer Cell Line Encyclopedia and the Cancer Therapeutics Response Portal. We demonstrate that accounting for the gene-centric dependencies enables leveraging information from multi-omic input data and improves prediction and feature selection performance. We further demonstrate the applicability of our method in an unsupervised dimensionality reduction application by inferring genes essential to tumorigenesis in the pancreatic ductal adenocarcinoma and lung adenocarcinoma patient cohorts from The Cancer Genome Atlas. Availability and Implementation: : The code for this work is available at https://github.com/olganikolova/gbgfa. Contact: : nikolova@ohsu.edu or margolin@ohsu.edu. Supplementary information: Supplementary data are available at Bioinformatics online.
Motivation: In recent years, vast advances in biomedical technologies and comprehensive sequencing have revealed the genomic landscape of common forms of humancancer in unprecedented detail. The broad heterogeneity of the disease calls for rapid development of personalized therapies. Translating the readily available genomic data into useful knowledge that can be applied in the clinic remains a challenge. Computational methods are needed to aid these efforts by robustly analyzing genome-scale data from distinct experimental platforms for prioritization of targets and treatments. Results: We propose a novel, biologically motivated, Bayesian multitask approach, which explicitly models gene-centric dependencies across multiple and distinct genomic platforms. We introduce a gene-wise prior and present a fully Bayesian formulation of a group factor analysis model. In supervised prediction applications, our multitask approach leverages similarities in response profiles of groups of drugs that are more likely to be related to true biological signal, which leads to more robust performance and improved generalization ability. We evaluate the performance of our method on molecularly characterized collections of cell lines profiled against two compound panels, namely the Cancer Cell Line Encyclopedia and the Cancer Therapeutics Response Portal. We demonstrate that accounting for the gene-centric dependencies enables leveraging information from multi-omic input data and improves prediction and feature selection performance. We further demonstrate the applicability of our method in an unsupervised dimensionality reduction application by inferring genes essential to tumorigenesis in the pancreatic ductal adenocarcinoma and lung adenocarcinomapatient cohorts from The Cancer Genome Atlas. Availability and Implementation: : The code for this work is available at https://github.com/olganikolova/gbgfa. Contact: : nikolova@ohsu.edu or margolin@ohsu.edu. Supplementary information: Supplementary data are available at Bioinformatics online.
Authors: Tess Orvis; Austin Hepperla; Vonn Walter; Ian J Davis; Bernard Weissman; Shujie Song; Jeremy Simon; Joel Parker; Matthew D Wilkerson; Nisarg Desai; Michael B Major; D Neil Hayes Journal: Cancer Res Date: 2014-08-12 Impact factor: 12.701
Authors: Pedro P Medina; Octavio A Romero; Takashi Kohno; Luis M Montuenga; Ruben Pio; Jun Yokota; Montse Sanchez-Cespedes Journal: Hum Mutat Date: 2008-05 Impact factor: 4.878
Authors: Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson Journal: Cell Date: 2012-09-14 Impact factor: 41.582
Authors: Yuan Yuan; Eliezer M Van Allen; Larsson Omberg; Nikhil Wagle; Ali Amin-Mansour; Artem Sokolov; Lauren A Byers; Yanxun Xu; Kenneth R Hess; Lixia Diao; Leng Han; Xuelin Huang; Michael S Lawrence; John N Weinstein; Josh M Stuart; Gordon B Mills; Levi A Garraway; Adam A Margolin; Gad Getz; Han Liang Journal: Nat Biotechnol Date: 2014-06-22 Impact factor: 54.908
Authors: Sarah M Haeger; Joshua J Thompson; Sean Kalra; Timothy G Cleaver; Daniel Merrick; Xiao-Jing Wang; Stephen P Malkoski Journal: Oncogene Date: 2015-04-20 Impact factor: 9.867
Authors: S Mitsunaga; M Ikeda; S Shimizu; I Ohno; J Furuse; M Inagaki; S Higashi; H Kato; K Terao; A Ochiai Journal: Br J Cancer Date: 2013-04-16 Impact factor: 7.640
Authors: David Croft; Antonio Fabregat Mundo; Robin Haw; Marija Milacic; Joel Weiser; Guanming Wu; Michael Caudy; Phani Garapati; Marc Gillespie; Maulik R Kamdar; Bijay Jassal; Steven Jupe; Lisa Matthews; Bruce May; Stanislav Palatnik; Karen Rothfels; Veronica Shamovsky; Heeyeon Song; Mark Williams; Ewan Birney; Henning Hermjakob; Lincoln Stein; Peter D'Eustachio Journal: Nucleic Acids Res Date: 2013-11-15 Impact factor: 16.971
Authors: Chang Xu; Olga Nikolova; Ryan S Basom; Ryan M Mitchell; Reid Shaw; Russell D Moser; Heuijoon Park; Kay E Gurley; Michael C Kao; Carlos L Green; Franz X Schaub; Robert L Diaz; Hallie A Swan; In S Jang; Justin Guinney; Vijayakrishna K Gadi; Adam A Margolin; Carla Grandori; Christopher J Kemp; Eduardo Méndez Journal: Clin Cancer Res Date: 2018-03-29 Impact factor: 12.531
Authors: Mehmet Gönen; Barbara A Weir; Glenn S Cowley; Francisca Vazquez; Yuanfang Guan; Alok Jaiswal; Masayuki Karasuyama; Vladislav Uzunangelov; Tao Wang; Aviad Tsherniak; Sara Howell; Daniel Marbach; Bruce Hoff; Thea C Norman; Antti Airola; Adrian Bivol; Kerstin Bunte; Daniel Carlin; Sahil Chopra; Alden Deran; Kyle Ellrott; Peddinti Gopalacharyulu; Kiley Graim; Samuel Kaski; Suleiman A Khan; Yulia Newton; Sam Ng; Tapio Pahikkala; Evan Paull; Artem Sokolov; Hao Tang; Jing Tang; Krister Wennerberg; Yang Xie; Xiaowei Zhan; Fan Zhu; Tero Aittokallio; Hiroshi Mamitsuka; Joshua M Stuart; Jesse S Boehm; David E Root; Guanghua Xiao; Gustavo Stolovitzky; William C Hahn; Adam A Margolin Journal: Cell Syst Date: 2017-10-04 Impact factor: 10.304
Authors: Kevin Meng-Lin; Choong Yong Ung; Taylor M Weiskittel; Alex Chen; Cheng Zhang; Cristina Correia; Hu Li Journal: J Bioinform Syst Biol Date: 2021-02-26